- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- September 2024
- 118 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- December 2024
- 373 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- June 2025
- 142 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- September 2024
- 150 Pages
Global
From €3538EUR$3,950USD£3,016GBP
- Report
- May 2023
- 274 Pages
Global
From €4796EUR$5,542USD£3,950GBP
- Report
- March 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
The AI Based Clinical Trial Solution market is a rapidly growing sector of the Clinical Trials industry. It is focused on the use of artificial intelligence (AI) to improve the efficiency and accuracy of clinical trials. AI-based solutions can be used to automate data collection, analysis, and reporting, as well as to identify and monitor potential risks. AI-based solutions can also be used to improve patient recruitment and engagement, and to reduce the cost and time associated with clinical trials.
AI-based solutions are being used to improve the accuracy and speed of data collection, analysis, and reporting. They can also be used to identify and monitor potential risks, as well as to improve patient recruitment and engagement. AI-based solutions are also being used to reduce the cost and time associated with clinical trials.
Some companies in the AI Based Clinical Trial Solution market include IBM Watson Health, Medidata Solutions, Oracle Health Sciences, and Clinerion. Show Less Read more
